Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004111
Filing Date
2025-02-14
Accepted
2025-02-14 16:26:09
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form5-02142025_090206.html 5  
1 form5-02142025_090206.xml 5 11692
  Complete submission text file 0001415889-25-004111.txt   13280
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MAPLES CORPORATE SERVICES LIMITED PO BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-11
Business Address
Badial Verender S. (Reporting) CIK: 0001870327 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-40598 | Film No.: 25629448